Exploration of Targeted Anti-tumor Therapy

OCT 19, 2026 · JOURNAL ARTICLE

Liquid biopsy in genitourinary cancers: circulating tumor DNA as a predictive biomarker for treatment selection and resistance monitoring

Exploration of Targeted Anti-tumor Therapy

Background: Genitourinary (GU) cancers—prostate, urothelial, and renal cell carcinomas (RCCs)—are a leading source of oncologic morbidity and mortality. Tumor heterogeneity and evo

OCT 9, 2026 · JOURNAL ARTICLE

Redefining axillary management by selecting patients for omission of sentinel lymph node surgery in early breast cancer

Exploration of Targeted Anti-tumor Therapy

Axillary staging has traditionally been performed routinely in early breast cancer to provide prognostic information and guide adjuvant therapy. In the era of targeted anti-tumor t

SEP 18, 2026 · JOURNAL ARTICLE

Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution

Exploration of Targeted Anti-tumor Therapy

Aim: Treatment approaches for biliary tract cancer (BTC) vary widely. Genomic profiling through next-generation sequencing (NGS) has made it possible to apply precision medicine in

SEP 14, 2026 · JOURNAL ARTICLE

Cardiotoxicity in breast cancer patients treated with chemoradiotherapy

Exploration of Targeted Anti-tumor Therapy

With national breast cancer screening programs leading to earlier diagnosis and improved treatments, more women are achieving long-term remission. However, this has resulted in ris

AUG 10, 2026 · JOURNAL ARTICLE

Bioethical challenges in the implementation of targeted anti-tumor therapies in low-resource settings: a perspective from Latin America

Exploration of Targeted Anti-tumor Therapy

An integrative bioethical review identifying systemic challenges and recommending policy frameworks for equitable implementation of precision oncology in resource-limited settings, grounded in normative ethical theory rather than empirical outcome data.